| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/ARCHNEUR.1997.00550210044011 |
| P698 | PubMed publication ID | 9311354 |
| P50 | author | Kristine Yaffe | Q18749055 |
| Laura P Sands | Q46618728 | ||
| P2093 | author name string | Browner W | |
| Cauley J | |||
| P433 | issue | 9 | |
| P304 | page(s) | 1110-1114 | |
| P577 | publication date | 1997-09-01 | |
| P1433 | published in | Archives of Neurology | Q15766672 |
| P1476 | title | Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women | |
| P478 | volume | 54 |
| Q33695738 | APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging |
| Q37154399 | APOE ε4, Alzheimer's disease pathology, cerebrovascular disease, and cognitive change over the years prior to death |
| Q21090806 | Accelerated cell aging in female APOE-ε4 carriers: implications for hormone therapy use |
| Q35130848 | Activation of estrogen receptor alpha increases and estrogen receptor beta decreases apolipoprotein E expression in hippocampus in vitro and in vivo |
| Q35060342 | Adjuvant breast cancer treatment and cognitive function: current knowledge and research directions |
| Q37317664 | Age and apolipoprotein E genotype influence rate of cognitive decline in nondemented elderly |
| Q38088622 | Alternative Approaches in Gene Discovery and Characterization in Alzheimer's Disease |
| Q34385463 | An Update on Postoperative Cognitive Dysfunction |
| Q36287844 | ApoE and quality of life in nonagenarians |
| Q30341746 | ApoE-dependent plasticity in Alzheimer's disease. |
| Q57616139 | Apolipoprotein E Polymorphism: A New Genetic Marker of Hip Fracture RiskThe Study of Osteoporotic Fractures |
| Q37009967 | Apolipoprotein E and cholesterol in aging and disease in the brain |
| Q74448431 | Apolipoprotein E epsilon 4 allele is not associated with the cognitive impairment in community-dwelling normal elderly individuals |
| Q53226841 | Apolipoprotein E epsilon 4, other risk factors, and course of Alzheimer's disease. |
| Q46089144 | Apolipoprotein E epsilon4 and change in cognitive functioning in community-dwelling older adults |
| Q36142719 | Apolipoprotein E epsilon4 and impaired episodic memory in community-dwelling elderly people: a marked sex difference. The Hordaland Health Study |
| Q45054674 | Apolipoprotein E genotype and lifetime cognitive decline. |
| Q47570801 | Apolipoprotein E genotype does not predict decline in intelligence in healthy older adults |
| Q53252049 | Apolipoprotein E, dementia and strokes. |
| Q33608563 | Apolipoprotein epsilon4 allele status, depressive symptoms, and cognitive decline in middle-aged and elderly persons without dementia |
| Q41696431 | Association between bone mineral density and cognitive decline in older women |
| Q53245633 | Association between the presenilin-1 mutation Glu318Gly and complaints of memory impairment. |
| Q43923291 | Associations between apolipoprotein E phenotype, glucose metabolism and cognitive function in men. An explorative study in a population sample |
| Q34832035 | Asymmetry in auditory and spatial attention span in normal elderly genetically at risk for Alzheimer's disease |
| Q35995579 | Blood pressure interacts with APOE ε4 to predict memory performance in a midlife sample |
| Q46598314 | Bone loss predicts subsequent cognitive decline in older women: the study of osteoporotic fractures |
| Q37705204 | CSF Apo-E levels associate with cognitive decline and MRI changes |
| Q34850830 | Characterization of vascular disease risk in postmenopausal women and its association with cognitive performance |
| Q36311526 | Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies |
| Q34478294 | Cognitive effects of standard-dose chemotherapy in patients with cancer |
| Q47593264 | Context-specific memory and apolipoprotein E (ApoE) epsilon 4: cognitive evidence from the NIMH prospective study of risk for Alzheimer's disease |
| Q33689729 | Cross-Sectional and Longitudinal Effects of CREB1 Genotypes on Individual Differences in Memory and Executive Function: Findings from the BLSA |
| Q34110671 | Current and future clinical trials for Alzheimer's disease: evolving ethical concerns |
| Q35029513 | Do aromatase inhibitors have adverse effects on cognitive function? |
| Q64247372 | Effects of APOE on cognitive aging in community-dwelling older adults |
| Q33975467 | Effects of family history and apolipoprotein E epsilon4 status on cognitive decline in the absence of Alzheimer dementia: the Cache County Study |
| Q38387513 | Estrogen receptor beta polymorphisms and cognitive performance in women: associations and modifications by genetic and environmental influences |
| Q36322578 | Estrogen receptor β in Alzheimer's disease: From mechanisms to therapeutics |
| Q51984880 | Estrogen replacement therapy and cognitive decline in older community women. |
| Q60628072 | Genetics of human prefrontal function |
| Q34458184 | Hippocampal atrophy rates and CSF biomarkers in elderly APOE2 normal subjects |
| Q33563135 | Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females |
| Q37154168 | Item response theory facilitated cocalibrating cognitive tests and reduced bias in estimated rates of decline |
| Q34252649 | Life extension factor klotho enhances cognition |
| Q35105806 | Low neuropsychologic performance among adult cancer survivors treated with chemotherapy |
| Q48866034 | MRI and genetic correlates of cognitive function in elders with memory impairment |
| Q52018805 | Memory performance in healthy elderly without Alzheimer's disease: effects of time and apolipoprotein-E. |
| Q35024617 | Mild cognitive impairment, dementia, and their subtypes in oldest old women |
| Q34072149 | Mild cognitive impairment: emerging therapeutics |
| Q36314026 | Neuroimaging and human genetics |
| Q34976296 | Neuroplasticity in Alzheimer's disease |
| Q34570703 | Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease |
| Q34411638 | Normal genetic variation, cognition, and aging |
| Q36073379 | Olfaction in aging and Alzheimer's disease: event-related potentials to a cross-modal odor-recognition memory task discriminate ApoE epsilon4+ and ApoE epsilon 4- individuals |
| Q53408146 | Physical Activity Throughout the Adult Life Span and Domain-Specific Cognitive Function in Old Age: A Systematic Review of Cross-Sectional and Longitudinal Data. |
| Q36869652 | Physical activity over the life course and its association with cognitive performance and impairment in old age. |
| Q46953738 | Pre-existing hypertension and the impact of stroke on cognitive function |
| Q43289323 | Presence of the APOE epsilon4 allele modifies the relationship between type 2 diabetes and cognitive performance: the Maine-Syracuse Study |
| Q34284146 | Sex differences in the association of the apolipoprotein E epsilon 4 allele with incidence of dementia, cognitive impairment, and decline |
| Q46447954 | Sleep-disordered breathing and cognition in older women |
| Q34621679 | Subjective cognitive concerns, episodic memory, and the APOE ε4 allele |
| Q48373488 | Tfm-AR modulates the effects of ApoE4 on cognition |
| Q50564711 | The Association of Apolipoprotein E Gene Polymorphism With Cognitive Performance in Nondemented Polish Adults Aged 55 to 75. |
| Q90574384 | The Role of Physical Fitness in Cognitive-Related Biomarkers in Persons at Genetic Risk of Familial Alzheimer's Disease |
| Q35560131 | The apolipoprotein E epsilon 2 allele and decline in episodic memory |
| Q24539024 | The apolipoprotein E gene, attention, and brain function |
| Q34951934 | The effects of estrogen replacement therapy on neuropsychological functioning in postmenopausal women with and without dementia: a critical and theoretical review |
| Q33799158 | The evolution of Alzheimer disease, the reproductive schedule, and apoE isoforms |
| Q48528814 | The influence of apolipoprotein E Epsilon4 polymorphism on qEEG profiles in healthy young females: a resting EEG study |
| Q50683180 | The relationship of APOE genotype to cognitive functioning in older African-American and Caucasian community residents. |
| Q78944637 | Type 2 diabetes mellitus and cognition: an understudied issue in women's health |
Search more.